Chris Eng of OSK Research explains how the Mitsui purchase fits into Khazanah's long term strategy and indicates good potential in healthcare in this region. With expertise from Japan's healthcare; one of best in world, lower cost than United States, local entities could learn from them about retirement care, age care and medical devices.
For hospitals under Integrated Healthcare, it's business as usual for the time being, and it gets to leverage on Mitsui connections. Will wait and see in medium term where Mitsui plans to take this 30% investment.
Mitsui & Co Ltd of Japan has bought a 30% stake in Integrated Healthcare Holdings Sdn Bhd, which controls Parkway and Pantai hospitals, for RM3.3 billion, in the largest Japanese investment in healthcare in the region.
Healthcare sector in Malaysia due for rerating as with integrated health city coming up and Iskandar wellness centre, a lot of potential. KPJ Healthcare's share price reached a 52-week high on Thursday of RM4.20, enjoying a halo effect from Mitsui deal and Goldis' plans to sell stake in Hoepharma Holdings.
At this point, not much further upside to KPJ's target price of RM4.62 from OSK. Would not advise buying aggressively at this level, while waiting for KPJ's Q1 results to be announced.
See omnystudio.com/listener for privacy information.